Acutus Medical (Acutus Medical) Debt-to-Equity : -43.78 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Acutus Medical Debt-to-Equity?

Acutus Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $2.58 Mil. Acutus Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $35.90 Mil. Acutus Medical's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-0.88 Mil. Acutus Medical's debt to equity for the quarter that ended in Dec. 2023 was -43.78.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Acutus Medical's Debt-to-Equity or its related term are showing as below:

AFIB' s Debt-to-Equity Range Over the Past 10 Years
Min: -43.78 Med: 0.07 Max: 0.52
Current: -43.78

During the past 6 years, the highest Debt-to-Equity Ratio of Acutus Medical was 0.52. The lowest was -43.78. And the median was 0.07.

AFIB's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.21 vs AFIB: -43.78

Acutus Medical Debt-to-Equity Historical Data

The historical data trend for Acutus Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acutus Medical Debt-to-Equity Chart

Acutus Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-0.18

0.33

0.43

0.52

-43.78

Acutus Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.52	0.64	0.89	1.23	-43.78

Competitive Comparison of Acutus Medical's Debt-to-Equity

For the Medical Devices subindustry, Acutus Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acutus Medical's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Acutus Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Acutus Medical's Debt-to-Equity falls into.

Acutus Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Acutus Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.582	+	35.897)	/	-0.879
	=	-43.78

Acutus Medical's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.582	+	35.897)	/	-0.879
	=	-43.78

Acutus Medical (OTCPK:AFIB) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Acutus Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Acutus Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Acutus Medical (Acutus Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acutus Medical Inc (OTCPK:AFIB) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2210 Faraday Avenue, Suite 100, Carlsbad, CA, USA, 92008

Website

https://www.acutusmedical.com

Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Europe.

Executives

Takeo Mukai	officer: Interim CFO	C/O ACUTUS MEDICAL, INC., 2210 FARADAY AVE., SUITE 100, CARLSBAD CA 92008
Jason K Garland	director	10000 WEHRLE DRIVE, CLARENCE NY 14031
Kevin Mathews	officer: SVP, Global Sales	C/O ACUTUS MEDICAL, INC., 2210 FARADAY AVE., SUITE 100, CARLSBAD CA 92008
Charlie Piscitello	officer: Chief People Officer	2210 FARADAY AVE #100, CARLSBAD CA 92008
Tom Sohn	officer: SVP, Gen. Counsel & Secretary	2210 FARADAY AVE #100, CARLSBAD CA 92008
R Scott Huennekens	director	C/O VOLCANO CORPORATION, 11455 EL CAMINO REAL, SUITE 460, SAN DIEGO CA 92130
James F. Hinrichs	director	3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Niamh Louise Pellegrini	director	C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY CA 94065
Orbimed Rof Ii Llc	director, 10 percent owner	601 LEXINGTON AVE., 54TH FLOOR, NEW YORK NY 10022
David P Bonita	director, 10 percent owner	C/O ORBIMED ADVISORS LLC, 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Orbimed Advisors Llc	director, 10 percent owner	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
James E Flynn	director, 10 percent owner, other: Director by Deputization	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Orbimed Capital Gp Iv Llc	director, 10 percent owner	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
John F Sheridan	director	C/O TANDEM DIABETES CARE, INC., 11045 ROSELLE STREET, SAN DIEGO CA 92121
David Roman	officer: SVP & Chief Financial Officer	ACUTUS MEDICAL, INC., 2210 FARADAY AVE, SUITE 100, CARLSBAD CA 92008